Generation of a Murine Model with a Central Nervous System Infection
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:21 min • July 8th, 2025
Loading...
Overview
This article describes a method for inducing central nervous system (CNS) infections in mouse pups using targeted viral injections. The procedure involves both intracerebral and intraperitoneal injections to facilitate localized and systemic viral spread.
Key Study Components
Area of Science
- Neuroscience
- Virology
- Infection Models
Background
- Understanding CNS infections is crucial for developing therapeutic strategies.
- Viral infections can lead to significant neurological damage and inflammation.
- This method allows for the study of viral pathogenesis in a controlled environment.
- Mouse models are commonly used to mimic human CNS infections.
Purpose of Study
- To establish a reliable model for studying CNS infections.
- To investigate the effects of viral infections on neuronal cells.
- To explore the immune response triggered by CNS infections.
Methods Used
- Preparation of viral solutions at specific concentrations.
- Intracerebral injection of a small volume of virus into the brain.
- Intraperitoneal injection of a larger volume of virus for systemic spread.
- Monitoring of infection progression and immune response.
Main Results
- Successful establishment of CNS infection in mouse pups.
- Observation of viral replication within neuronal cells.
- Induction of CNS inflammation as a response to the viral infection.
- Demonstration of the model's utility for studying viral pathogenesis.
Conclusions
- The dual injection method effectively models CNS infections.
- This model can be used to further understand viral impacts on the nervous system.
- Future studies can leverage this model to test therapeutic interventions.
Frequently Asked Questions
What is the significance of using mouse pups for CNS infection studies?
Mouse pups provide a controlled environment to study the effects of viral infections on the developing nervous system.
How does the injection technique bypass the blood-brain barrier?
Intracerebral injection directly delivers the virus to the brain, avoiding the blood-brain barrier.
What are the expected outcomes of the viral infection in this model?
Expected outcomes include viral replication, neuronal cell death, and immune response activation.
Can this model be used for other types of viral infections?
Yes, the methodology can be adapted for various viruses affecting the CNS.
What precautions should be taken during the injection process?
Proper sterilization and careful handling of the mouse pups are essential to prevent infection and ensure accurate results.
How can researchers monitor the progression of the infection?
Researchers can monitor clinical signs, perform histological analyses, and assess immune responses to evaluate infection progression.
Executive Industry Relevance
Establishing a murine model of central nervous system (CNS) infection enables early-stage evaluation of viral neurotropism and host-pathogen interactions relevant to neuroinflammatory disease. This model supports predictive confidence in target validation and mechanistic de-risking for antiviral and neuroprotective therapeutic discovery. Its reproducibility and quantitative outputs facilitate risk-adjusted portfolio decisions in preclinical neuroscience and infectious disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of viral entry, replication, and neuroinflammatory mechanisms in a controlled in vivo system.
- Supports functional target validation by modeling neuronal cell death and immune activation in response to CNS infection.
- Facilitates mechanistic de-risking for candidate targets implicated in neurotropic viral pathogenesis.
Screening & Assay Development
- Provides a validated biological system for downstream efficacy and toxicity screening of antiviral compounds.
- Enables standardization of infection parameters and quantitative assessment of disease progression.
- Supports reproducibility and scalability for comparative evaluation of therapeutic interventions.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints such as neuronal loss and CNS inflammation for translational biomarker development.
- Enables continuity from discovery through preclinical validation of neuroprotective or antiviral strategies.
- Supports risk-adjusted advancement decisions based on in vivo predictive value.
Pipeline & Workflow Integration
This murine CNS infection model is positioned at the interface of early discovery and preclinical validation, supporting hypothesis testing and lead identification for neurotropic viral diseases.
- Discovery Biology: Facilitates hypothesis-driven interrogation of viral pathogenesis and host response in the CNS.
- Screening: Provides a reproducible platform for quantitative assessment of infection severity and therapeutic efficacy.
- Analytics: Enables measurement of neuronal cell death, inflammation, and clinical symptom progression for comparative analysis.
- Translational Research: Supports alignment with disease-relevant biomarkers and endpoints for preclinical studies.
- Enterprise Reuse: Offers a reusable in vivo system adaptable to various neurotropic viruses and intervention strategies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic understanding of CNS infection.
- Operational Value: Standardizes in vivo infection protocols for reproducibility and scalability across studies.
- Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk in neuroinfectious disease portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization of antiviral and neuroprotective candidates for advancement.
Implementation Considerations
- Requires expertise in murine handling, intracerebral and intraperitoneal injection techniques.
- Demands access to virology and animal facility infrastructure for infection and monitoring.
- Necessitates cross-team standardization of viral titers, injection volumes, and clinical assessment criteria.
- Adaptation may be needed for different viral strains or mouse genetic backgrounds.
- Limitations include age-specific susceptibility and potential variability in CNS infection outcomes.
Biopharma FAQs
Why is null hypothesis testing critical in CNS infection modeling?
Null hypothesis testing enables objective evaluation of whether observed neuronal cell death and inflammation are attributable to viral infection versus baseline variability, supporting robust target validation in neuroinfectious disease research.
How does independent variable isolation enhance viral injection studies?
Isolating variables such as injection route and viral dose allows teams to attribute CNS infection outcomes specifically to experimental manipulations, strengthening mechanistic insights and discovery-stage decision making.
What do quantitative dependent variable measurements enable in this model?
Quantitative assessment of neuronal loss, inflammation, and clinical symptoms provides actionable data for comparing intervention efficacy and advancing candidates with predictive translational value.
Why are replication requirements important for cross-functional CNS infection studies?
Replication ensures that CNS infection phenotypes and therapeutic responses are reproducible across teams, supporting cross-functional collaboration and enterprise-wide confidence in preclinical findings.
What statistical analysis capabilities are needed before implementing CNS infection models?
Teams require statistical tools to analyze infection severity, neuronal loss, and symptom progression, enabling rigorous comparison of experimental groups and informed advancement decisions in the R&D pipeline.
07:26
Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Related Videos
0 Views
08:03
In Vivo Mouse Model of Spinal Implant Infection
Related Videos
0 Views
08:48
A Rat Model of EcoHIV Brain Infection
Related Videos
0 Views
05:11
Murine Perineural Invasion Model: Generating an In Vivo Model to Simulate Perineural Invasion in Mouse Sciatic Nerve
Related Videos
0 Views
04:00
A Murine Skin Wound Infection Model to Study the Immune Response against a Bacterial Pathogen
Related Videos
0 Views
03:28
Generation of a Mouse Model of Experimental Cerebral Malaria Using Host Mosquito-Derived Sporozoites
Related Videos
0 Views
02:59
An Intracerebroventricular Injection to Analyze Murine Cytomegalovirus Distribution in a Neonatal Mouse Brain
Related Videos
0 Views
02:00
Generating Virus-Induced Neuroinflammation in a Mouse Model
Related Videos
0 Views
05:53
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Related Videos
0 Views
11:40
Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Related Videos
0 Views
Last updated: 18 July 2026